James C Hamilton Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

James C Hamilton is Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 262,122 shares of ARWR, which is worth approximately $4.67 Million. The most recent transaction as insider was on Aug 15, 2025, when has been sold 9,389 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $187,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 262K

3.67% 3M change

27.96% 12M change

Total Value Held $4.67 Million

James C Hamilton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2025	SELL Open market or private sale	$187,780 $20.0 p/Share	9,389 Reduced 3.46%	262,122 Common Stock
Aug 13 2025	SELL Open market or private sale	$12,220 $20.0 p/Share	611 Reduced 0.22%	271,511 Common Stock
Jan 06 2025	SELL Open market or private sale	$651,307 $19.9 p/Share	32,729 Reduced 10.74%	272,122 Common Stock
Jan 04 2025	BUY Grant, award, or other acquisition	-	100,000 Added 24.7%	304,851 Common Stock
Apr 01 2024	SELL Open market or private sale	$168,180 $28.03 p/Share	6,000 Reduced 2.85%	204,851 Common Stock
Jan 12 2024	SELL Open market or private sale	$293,144 $36.92 p/Share	7,940 Reduced 3.63%	210,851 Common Stock
Jan 05 2024	SELL Open market or private sale	$1,121,790 $34.9 p/Share	32,143 Reduced 12.81%	218,791 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	75,000 Added 23.01%	250,934 Common Stock
Jan 03 2024	SELL Open market or private sale	$205,002 $32.54 p/Share	6,300 Reduced 3.46%	175,934 Common Stock
Jun 30 2023	SELL Open market or private sale	$106,590 $35.53 p/Share	3,000 Reduced 1.57%	188,484 Common Stock
Jan 05 2023	SELL Open market or private sale	$516,232 $37.4 p/Share	13,803 Reduced 6.72%	191,484 Common Stock
Jan 04 2023	BUY Grant, award, or other acquisition	-	60,000 Added 22.62%	205,287 Common Stock
Jan 03 2023	SELL Open market or private sale	$403,698 $39.05 p/Share	10,338 Reduced 6.64%	145,287 Common Stock
Jan 05 2022	SELL Open market or private sale	$391,250 $62.6 p/Share	6,250 Reduced 3.86%	155,625 Common Stock
Jan 04 2022	SELL Open market or private sale	$1,299,481 $67.07 p/Share	19,375 Reduced 10.69%	161,875 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	55,000 Added 23.28%	181,250 Common Stock
Jan 14 2021	SELL Open market or private sale	$814,000 $81.4 p/Share	10,000 Reduced 7.34%	126,250 Common Stock
Jan 06 2021	SELL Open market or private sale	$1,392,481 $71.87 p/Share	19,375 Reduced 12.45%	136,250 Common Stock
Jan 05 2021	SELL Open market or private sale	$1,405,269 $72.53 p/Share	19,375 Reduced 11.07%	155,625 Common Stock
Jan 01 2021	BUY Grant, award, or other acquisition	-	50,000 Added 22.22%	175,000 Common Stock

JCH

James C Hamilton

Chief Medical Officer

Pasadena, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Value

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Track Activities on ARWR

Account